Location London, England, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
Investor Type
LinkedIn View on LinkedIn
Ted Fjällman is a Chief Executive Officer at NorthX Biologics. He Attended London Business School.
Overview
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Synerkine Pharma |  Flerie Invest | Series A - Synerkine Pharma | |||
 XNK Therapeutics | Flerie Invest | Venture Round - XNK Therapeutics | |||
 Geneos Therapeutics | Flerie Invest | Series A - Geneos Therapeutics | |||
Synerkine Pharma | Flerie Invest | Series A - Synerkine Pharma |
Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
 NorthX Biologics | |||
 Prokarium | |||
Prokarium |
